Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma
Tadatoshi Takayama(Nihon University), Yoshiharu Motoo(Fukui-ken Saiseikai Hospital), Nobuo Okazaki, Masatoshi Makuuchi, Hiroshi Hasegawa(Shibaura Institute of Technology), Michiie Sakamoto(Keio University), Susumu Yamazaki(Tokyo National Hospital), T Kosuge(Tokyo National Hospital), S Hirohashi(National Cancer Research Institute), Kenichi Takayasu
Cited by 419
Related Papers
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
|Cancer|1985|1.9k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Ultrasonically guided subsegmentectomy.
|PubMed|1985|823
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780